Idiopathic hypereosinophilic syndrome

Search Trials
Efficacy of Imatinib Mesylate in Hypereosinophilic Syndromes
Status:
Completed
Last Changed:
Dec 29, 2010
First Changed:
Nov 7, 2008
Disease(s):
Hypereosinophilic Syndrome
Intervention(s):
Imatinib
Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome
Status:
Completed
Last Changed:
Mar 4, 2008
First Changed:
Apr 29, 2002
Disease(s):
Hypereosinophilic Syndrome
Intervention(s):
SCH55700
Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome
Status:
Recruiting
Last Changed:
Apr 22, 2022
First Changed:
Aug 26, 2002
Disease(s):
Hypereosinophilic Syndrome
Intervention(s):
ImatinibRuxolitinib
Intravenous Mepolizumab In Subjects With Hypereosinophilic Syndromes (HES)
Status:
Completed
Last Changed:
May 5, 2020
First Changed:
Jul 9, 2004
Disease(s):
Hypereosinophilia
Intervention(s):
mepolizumab

Connect. Empower. Inspire.